Artificial intelligence and the Pharma industry. What should CIOs be doing?

Artificial intelligence has the potential to transform healthcare and the pharma industry; making health services more predictive, more effective and more equitable. But can AI's potential be realised, and what can chief information officers and clinical chief information officers do to get the most out of the new technology? The Healthcare Information and Management Systems Society (HIMSS) Executive Leadership summit last month attended by NHS CIOs and CCIOs, leaders from NHS England and NHS Digital and other health IT innovators, expressed the potential AI-driven data analytics has in supporting the NHS's Five Year Forward View, narrowing gaps in health provision. The summit discussed how AI could address the health and wellbeing gap by predicting which individuals most risk illness, allowing the NHS to target treatments accordingly, with AI giving health professionals and patients bespoke diagnostics and treatments. It was also noted that AI could help address the efficiency and funding gap by automating tasks, triaging patients to the most appropriate services and allowing them to self-care.